CORVAS INTERNATIONAL INC
10-C, 1996-07-12
PHARMACEUTICAL PREPARATIONS
Previous: GILEAD SCIENCES INC, S-8, 1996-07-12
Next: TARGET THERAPEUTICS INC, S-3, 1996-07-12



<PAGE>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                   FORM 10-C 


                 REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                          INTERDEALER QUOTATION SYSTEM


  FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                      AND RULE 13a-17 OR 15d-17 THEREUNDER


                           CORVAS INTERNATIONAL, INC.
                       -----------------------------------
                 (Exact name of issuer as specified in charter)


                  3030 Science Park Drive, San Diego, CA 92121
               --------------------------------------------------
                    (Address of principal executive offices)



Issuer's telephone number, including area code: (619) 455-9800
                                                -----------------------------


                  I. CHANGE IN NUMBER OF SHARES OF OUTSTANDING


Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:

1.   Title of Security:   Common Stock ($0.001 par value)
                          -----------------------------------------------------


2.   Number of shares outstanding before the change:  12,699,791
                                                     --------------------------

3.   Number of shares outstanding after the change:   13,699,791
                                                     ---------------------------

4.   Effective date of change:  July 2, 1996
                                ------------------------------------------------

5.   Method of change:

     Specify method (such as merger, acquisition, exchange, distribution, stock
     split, reverse split, acquisition of stock for treasury, etc.):  Sale of
                                                                      --------
     Common Stock ($0.001 par value) for cash.
     ----------------------------------------

     Give brief description of transaction:  Sale of 1,000,000 registered shares
                                             -----------------------------------
     of Common Stock by the Company on a best efforts basis to selected
     ---------------------------------------------------------------------------
     institutional investors.
     ---------------------------------------------------------------------------



Date:  July 12, 1996                         /s/ JOHN E. CRAWFORD
                                             ------------------------------
                                             John E. Crawford
                                             Executive Vice President
                                             and Chief Financial Officer
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission